Skip to main content

Table 3 Associations of dietary patterns with HOMA-IR and HbA1c in The Maastricht Study

From: Plasma metabolomic profiling of dietary patterns associated with glucose metabolism status: The Maastricht Study

Variables

Overall

Male

Female

Obesity (BMI≥30)

Non-obesity (BMI<30)

β

95% CI

P

β

95% CI

P

β

95% CI

P

β

95% CI

P

β

95% CI

P

HOMA-IR

 MED

−0.086

−0.111, −0.061

<0.001

−0.094

−0.132, −0.056

<0.001

−0.082

−0.114, −0.051

<0.001

−0.058

−0.130, 0.014

0.114

−0.056

−0.077, −0.036

<0.001

 DASH

−0.034

−0.043, −0.024

<0.001

−0.136

−0.213, −0.058

<0.001

−0.029

−0.043, −0.015

<0.001

−0.030

−0.057, 0.004

0.065

−0.018

−0.026, −0.011

<0.001

 DHD

−0.013

−0.016, −0.010

<0.001

−0.009

−0.013, −0.006

<0.001

−0.011

−0.015, −0.007

<0.001

−0.009

−0.017, 0.001

0.076

−0.007

−0.010, −0.005

<0.001

HbA1c

 MED

−0.716

−0.913, −0.519

<0.001

−0.404

−0.636, −0.173

<0.001

−1.075

−1.382, −0.766

<0.001

−1.052

−1.586, −0.519

<0.001

−0.415

−0.603, −0.226

<0.001

 DASH

−0.191

−0.262, −0.121

<0.001

−0.187

−0.269, −0.104

<0.001

−0.187

−0.269, −0.104

<0.001

−0.335

−0.531, −0.139

<0.001

−0.061

−0.129, −0.006

0.007

 DHD

−0.098

−0.120, −0.076

<0.001

−0.049

−0.076, −0.021

<0.001

−0.092

−0.128, −0.057

<0.001

−0.148

−0.207, −0.089

<0.001

−0.044

−0.065, −0.023

<0.001

  1. The intervals of glucose metabolism statuses were defined as follows: NGM, fasting plasma glucose <6.1 mmol/L; prediabetes, fasting plasma glucose of 6.1–6.9 mmol/L and no hypoglycaemic medications; type 2 diabetes, fasting plasma glucose ≥7.0 mmol/L or hypoglycaemic medications
  2. The adjustments included age (years, continuous), sex (male or female), BMI (kg/m2, continuous), level of education (low, middle or high), level of household income (<2000 euros/month, 2000–3750 euros/month, or ≥3750 euros/month), smoking status (never, current or former smoker), daily energy intake (kcal/d, continuous), daily glucose intake (mmol/mol, continuous), estimated glomerular filtration rate (eGFR, ml/min, continuous), total physical activity (h/week, continuous), usage of lipid-modification medication (no or yes), history of cardiovascular disease (no or yes), and the year for metabolomics measurement (2014 or 2016) if applicable
  3. Reference group was tertile 1
  4. P<0.05 was considered statistically significant
  5. Abbreviations: NGM normal glucose metabolism, BMI body mass index, kcal kilocalories, MED Mediterranean Diet, DASH Dietary Approaches to Stop Hypertension diet, DHD Dutch Healthy Diet, HOMA-IR homeostatic model assessment for insulin resistance, HbA1c haemoglobin A1c